Critical roles for murine Reck in the regulation of vascular patterning and stabilization

de Almeida, Glícia Maria; Yamamoto, Mako; Morioka, Yoko; Ogawa, Shuichiro; Matsuzaki, Tomoko; Noda, Makoto

doi:10.1038/srep17860

Download PDF

Article
Open access
Published: 11 December 2015

Critical roles for murine Reck in the regulation of vascular patterning and stabilization

Glícia Maria de Almeida¹^na1,
Mako Yamamoto¹^na1^nAff2,
Yoko Morioka¹^na1,
Shuichiro Ogawa¹^na1,
Tomoko Matsuzaki¹^na1 &
…
Makoto Noda¹^na1

Scientific Reports volume 5, Article number: 17860 (2015) Cite this article

1850 Accesses
22 Citations
Metrics details

Subjects

A Corrigendum to this article was published on 04 March 2016

This article has been updated

Abstract

Extracellular matrix (ECM) is known to play several important roles in vascular development, although the molecular mechanisms behind these remain largely unknown. RECK, a tumor suppressor downregulated in a wide variety of cancers, encodes a membrane-anchored matrix-metalloproteinase-regulator. Mice lacking functional Reck die in utero, demonstrating its importance for mammalian embryogenesis; however, the underlying causes of mid-gestation lethality remain unclear. Using Reck conditional knockout mice, we have now demonstrated that the lack of Reck in vascular mural cells is largely responsible for mid-gestation lethality. Experiments using cultured aortic explants further revealed that Reck is essential for at least two events in sprouting angiogenesis; (1) correct association of mural and endothelial tip cells to the microvessels and (2) maintenance of fibronectin matrix surrounding the vessels. These findings demonstrate the importance of appropriate cell-cell interactions and ECM maintenance for angiogenesis and the involvement of Reck as a critical regulator of these events.

EPAC2 acts as a negative regulator in Matrigel-driven tubulogenesis of human microvascular endothelial cells

Article Open access 30 September 2021

Med23 supports angiogenesis and maintains vascular integrity through negative regulation of angiopoietin2 expression

Article Open access 19 April 2022

Enhanced endothelial motility and multicellular sprouting is mediated by the scaffold protein TKS4

Article Open access 07 October 2019

Introduction

Correct vascular development is crucial for all aspects of tissue growth and physiology in vertebrates. In mammals, two families of cytokines; vascular endothelial growth factors (VEGFs) and angiopoietins, are known to play a lead role in angiogenesis^1,2,3,4,5. Early events during sprouting angiogenesis involve specialization of activated endothelial cells into two distinct subtypes: namely, tip and stalk cells. VEGF stimulates the expression of tip cell markers, including Flk1 and Notch-ligands of which the Notch-ligands stimulate Notch-signaling in adjacent cells to suppress their tip cell phenotype (lateral inhibition) and induce the phenotype of lumen-forming stalk cells⁶. For vascular stabilization, endothelial tubes need to recruit and be tightly associated with, mural cells (i. e., vascular smooth muscle cells and pericytes), whilst platelet-derived growth factor (PDGF) serves as a key attractant in this process⁷. This cell-cell interaction triggers the perivascular deposition of extracellular matrix (ECM) components, such as fibronectin (FN) and vascular basement membrane (vBM) to promote vessel maturation and stabilization^8,9. Matrix metalloproteinases (MMPs) are also known to play major roles in the ECM-remodeling associated with angiogenesis^10,11, although how this process is regulated remains to be elucidated.

RECK, conserved as a single gene from insects to primates, encodes a membrane-anchored regulator of multiple metalloproteinases, including several members of the MMP family^{12,13,14,15,16,17,18}. In mammalian cells, RECK expression is downregulated by various external stimuli, such as growth factors, low cell density and low oxygen^19,20,21. RECK expression is also downregulated frequently in cancer cells and restoration of RECK expression in such cells results in suppression of tumor angiogenesis, invasion and metastasis in xenograft models^14,17. Recent evidence indicates that several oncogenic microRNAs target RECK mRNA^{20,22,23,24,25,26}, strengthening the notion that RECK is a tumor suppressor that is downregulated via various mechanisms during carcinogenesis.

Previous studies have also revealed the critical functions of Reck in mammalian development. Mice lacking Reck-expression die in utero around embryonic day 10.5 (E10.5), exhibiting reduced tissue integrity, arrested vasculogenesis¹³ and precocious neuronal differentiation^13,16. A mouse mutant with reduced Reck-expression (Reck^Low/∆, see below) demonstrates defects in limb patterning; a phenotype that can be explained by impaired Wnt7a-signalling due to tissue damage in limb-bud mesenchyme and overlaying dorsal epithelium²¹. In some rapidly proliferating tissues, such as embryos and uterine implantation chambers, Reck expression is abundant in both vascular endothelial cells and mural cells²⁷. Dilated vessels with abnormal luminal shapes can be observed in these tissues in mice with reduced Reck expression. Abundant Reck-expression has also been found in fibroblastic cells associated with bifurcating vessels, leading to the speculation that Reck may play a role in non-sprouting angiogenesis (e.g., intussusception and pruning)²⁷.

In the present study, we dissected the roles for Reck in different vascular cell types during angiogenesis by using multiple lines of newly developed Reck mutant mice. We also employed aortic ring assay (ARA)^28,29 to assess the ability of aortic tissue explants to form small vessels (microvessels) in vitro. We found that selective inactivation of Reck in vascular mural cells caused embryonic death around E10.5 with vascular defects, suggesting that the mid-gestation lethality of Reck-null mice can be attributed to the absence of Reck in mural cells. In addition, we unexpectedly found that impaired Reck function leads to excessive sprouting of unstable microvessels in vitro, raising the possibility that the abnormal, dilated vessels found in Reck-deficient mice may arise by lateral fusion of unstable vessels rather than, or in addition to, abortive intussusception.

Results

Cell type-selective inactivation of Reck in vivo

The engineered Reck alleles in mice used in this study are listed in Fig. 1a: (1) Reck^-, the original null-allele¹³, (2) Reck^CrER, expressing the tamoxifen-regulatable Cre recombinase CreER^T2 from the Reck locus (Matsuzaki et al. in preparation); (3) Reck^E1fx, containing two lox-P sites flanking exon-1; (4) Reck^∆, a novel null-allele lacking proximal promoter plus exon-1; and (5) Reck^Low, a hypomorphic allele expressing Reck at ~50% of the wild type (wt) level²¹. In addition, we utilized two Cre transgenic lines, Sm22-Cre³⁰ and Tie2-Cre³¹, to induce loxP-recombination selectively in mural and endothelial cells, respectively.

Visualization of Reck-positive cells in the yolk sac at embryonic day 10.5 (E10.5), using mice carrying the Reck^CrER allele together with the mTmG reporter system³², revealed that the majority of Reck-mG cells (green; Fig. 1b-1) exhibit cobble stone-like alignment resembling that of Sm22-mG vascular mural cells (green, Fig. 1b-2). This phenotype was widespread, rather than the dendritic pattern of Tie2-mG vascular endothelial cells (green, Fig. 1b-3), although some cells with ambiguous morphology were also observed (e.g, Fig. 1b-1, arrowhead).

First, to assess the contribution of mural Reck to vascular development, Reck was inactivated using the Sm22-Cre driver mouse (Supplementary Fig. S1a,b). The resulting mutant mice, termed Reck cKO (Sm), were reminiscent of Reck^−/− mice^13,27 in that they died around E10.5 (Fig. 1c, triangles) with smaller body size (Fig. 1d-4), poor vascularization in the neural tube (Fig. 1d-5) and dilated perineural vasculature with peculiar luminal shape (Fig. 1d-6). As reported previously, Reck^−/− embryos displayed reduced tissue integrity (Fig. 1e-7) with frequent breakage of the neural tube (e.g., Fig. 1e-8, arrowhead)². Although Reck cKO (Sm) embryos were not as fragile (Fig. 1e-4), they shared some phenotypes with Reck^−/− mice such as frequent breakage of dorsal aorta (Fig. 1e-5) and pericardial membrane (Fig. 1e-6). Hence, the mid-gestation lethality of Reck-null mice¹³ may largely be attributable to the Reck-deficiency in mural cells.

Next, to assess the contribution of endothelial Reck, Reck was inactivated using the Tie2-Cre mouse (Supplementary Fig. S1c,d). Although the mutant mice, termed Reck cKO (Tie), survived beyond E10.5, they died before birth (Fig. 1c, squares) and exhibited intra-cranial hemorrhage (Fig. 1f-2; Fig. 1g, panels 6–8) with severe abnormalities in vasculature and cytoarchitecture in their cerebral cortex (Fig. 1g, panels 7–10). Hence, Reck in Tie2-positive cells is indispensable for later-stage embryogenesis, particularly within the brain.

Effects of Reck-deficiency on microvessel formation

To understand the roles of Reck at the cellular level, ARAs^28,29 were utilized, which allowed assessment of the ability of dorsal aorta tissue pieces (aortic rings) to form microvessels in vitro. Aortae from 5-weeks old, tamoxifen-induced Reck knockout (Reck cKO) and control (Cont) mice carrying the mTmG reporter were used. Under optimized conditions (Supplementary Figs S2 and S3a), control aortic rings showed a slow but steady increase in microvessel number over the time course observed (Fig. 2a, blue line), whereas Reck cKO samples showed an initial rapid increase (up to day 10) followed by a decline (from day 12) in the number of microvessels (Fig. 2a, red line). This decline was accompanied by aggregation and thickening of microvessels (Fig. 2b-8, 9, arrowheads; Supplementary Fig. S3b,c). Morphometry of fluorescent images (Fig. 2c-f and Supplementary Fig. S4) indicated that the Reck cKO microvessels were wider (Fig. 2c) and covered a broader area (Fig. 2d) with lower lacunarity (Fig. 2e). In addition, Reck cKO aortic rings were often accompanied by peri-aortic halos, indicating increased local lysis of collagen gel³³ (Fig. 2b-10, arrow; Fig. 2f). Thus, Reck–deficiency leads to the formation of an excessive number of unstable microvessels in this assay.

Identity of Reck-mG cells

To determine how Reck-deficiency leads to such microvessel phenotypes, the nature of Reck-mG cells in ARA was examined. In control cultures, some Reck-mG cells localize at microvessel tips (Fig. 3a-1, arrowhead), whilst others are associated with microvessel stalks (Fig. 3a-1, arrow). The former look similar to the Tie2-mG or CD31-positive endothelial cells (Fig. 3a-2, arrowhead; Supplementary Fig. S5a, magenta) and the latter the Sm22-mG-positive mural cells (Fig. 3a-3, arrow; Supplementary Fig. S5a, green). Immunofluorescent staining for another mural marker, αSMA, often detected Reck-mG/αSMA double-positive (i.e., mural Reck-mG) cells surrounding microvessel stalks (Fig. 3b-3 and Supplementary Fig. S6-3, white signals as indicated by arrows); CD31-staining detected Reck-mG/CD31 double-positive (endothelial Reck-mG) cells near microvessel tips (Fig. 3b-9 and Supplementary Fig. S6-9, white signals as indicated by arrowheads) along with Reck-mG single-positive (non-endothelial Reck-mG) cells surrounding microvessel stalks (Fig. 3b-9 and Supplementary Fig. S6-9, green signals). Reck-mG cells found near microvessel tips were often positive for a vascular tip cell marker, Flk1 (Fig. 3c-2, magenta). These results, together with morphometric data (Fig. 3d, e), indicate that Reck-mG cells in control cultures contain both mural (ca. 70%; Fig. 3d, bar 9) and endothelial (ca. 30%; Fig. 3e, bar 9) populations.

Effects of Reck on the number and behaviors of Reck-mG cells

Reck-deficiency had multiple effects on Reck-mG cells. First, the number of Reck-mG cells surrounding an aortic ring was increased (Fig. 4a) whilst Ki67-staining revealed increased proliferation of both microvessel-associated and non-associated cells (Supplementary Fig. S5b and c, magenta). Second, the proportion of mural Reck-mG cells was decreased (Fig. 3d, bars 6, 12) whereas that of Reck-mG-negative endothelial cells was increased (Fig. 3e, bar 4). Third, endothelial Reck-mG cells were seldom found at microvessel tips in Reck cKO samples (Fig. 3b-12 and Supplementary Fig. S6-12, arrowheads; Supplementary Fig. S5d). Fourth, tight association of Reck-mG cells with microvessel stalks was somehow impaired (Figs. 4b-3 and -4; Fig. 4c, d); consistent to this finding in vitro, large aortae were frequently surrounded partially and unevenly by αSMA-positive mural cells that are not so tightly associated with a vessel as the control (Figs 4e-1) in sections of Reck^−/− embryos at E10.5 (Figs 4e-2). Partial and uneven coverage of large aortae by αSMA-positive cells was also found in Reck cKO (Sm) embryos at E10.5 (Fig. 4f, g), suggesting a cell-autonomous function of Reck manifested in this phenotype. In addition, the irregularly spaced small vessels (CD31-positive) in the neural tube of Reck cKO (Sm) mice were seldom accompanied by αSMA-positive mural cells (Figs 1d-5 and 6). Taken together, these findings suggest that Reck is required to achieve adequate compositions of and interactions between, vessel-forming cells.

Functional relationship between Reck and FN in microvessel formation

FN and its receptor are known to be protected by RECK^18,34,35. In ARA with Reck-positive cells, abundant FN fibrils could be visualized by immunofluorescent staining (Fig. 5a, panel 3 and 7) and prominent signals were found in the areas where mural (Sm22-mG) cells tightly associated with microvessels (Fig. 5a, panels 1–4, arrows). Near the tips of these microvessels, localized loss of FN fibrils were found near microvessel tips (Fig. 5a, panel 5–8, arrow). In Reck cKO cultures, signals for both FN (Fig. 5a-11) and laminin α 5 (Lama5), a component of vBM (Fig. 5b-5), were dampened and diffuse. When Reck cKO aortic rings were embedded in collagen gel supplemented with purified FN (Fig. 5c), some Reck cKO phenotypes, such as increased number, width and aggregation of microvessels, increased area covered by microvessels and decreased lacunarity of vascular network, were significantly suppressed (Fig. 5c-g) with increased perivascular FN- and Lama5-immunoreactivity (Supplementary Fig. S7a and b). Other Reck cKO phenotypes, such as peri-aortic halo and poor association of Reck-mG cells with microvessels, were not fully suppressed by FN supplementation (Fig. 5h, i). Hence, some Reck cKO phenotypes in ARA, such as excessive sprouting and destabilized microvessels, may be attributable to the reduced ambient FN in the absence of Reck.

Discussion

In this study, the importance of Reck in both mural and endothelial cells was documented in vivo and in vitro. Although selective inactivation of Reck in mural cells in vivo resulted in mid-gestation lethality and vascular defects reminiscent of Reck-null mice (Fig. 1c–e and ref. 2)Reck-inactivation in Tie2-positive cells also resulted in embryonic death, albeit at later stages with major impacts in the brain (Fig. 1c, f,g). In vitro, Reck-positive cells contribute to both mural and endothelial lineages (Fig. 3) whilst Reck-inactivation results in increased sprouting, decreased microvessel stability (Fig. 2) and altered composition (Fig. 3d–f) alongside a change in behavior that includes defective localization and reduced association (Figs 3b,4; Supplementary Fig. S5d) of vascular cells whose normal counterparts express Reck.

Senger, Stratman and Davis have proposed that mural-endothelial interaction triggers perivascular FN-deposition and subsequent vBM-deposition required for vascular stability in vivo ^8,9. Our data in vitro suggest that Reck plays a key role in this process by protecting FN from degradation (Supplementary Fig. S7c). The failure of FN to fully normalize the association of Reck-mG cells to the microvessels (Fig. 5i) fits with this model, (Supplementary Fig.S7c) which places the mural-endothelial interaction upstream of FN-deposition; raising a new question as to how Reck promotes this upstream event. Attenuated PDGF-receptor immunoreactivity found in Reck-deficient cells (Supplementary Fig. S8a and b) may be suggestive of its involvement in this failure, since PDGF is known to play a key role in pericyte-recruitment by endothelial cells ³⁶ (Supplementary Fig. S8d-1).

The mechanism underlying the contribution of Reck-deficiency to the mislocalization of Reck-mG tip cells is presently unclear but several hypotheses can be envisaged. In Reck cKO culture, Flk1 signals were dampened and scarce in cells at the microvessel tips (Supplementary Fig. S5d, magenta), suggesting abortive tip-stalk specification. Reck-deficient mice exhibit precocious neuronal differentiation and this has been explained by attenuated Notch-signaling in neural precursor cells, due to de-regulated Adam10 that clips off Notch-ligands from adjacent cells¹⁶. In the vascular system, Notch signaling is known to suppress the tip cell phenotype and to promote acquisition of the stalk cell phenotype⁶. Hence, an obvious model is that attenuated Notch-signaling in this system leads to ectopic expression of tip cell phenotype, which can explain the excessive sprouting found in Reck cKO rings in ARA. This model, however, predicts upregulation and/or ectopic expression of tip-cell markers (such as Flk1), but this was not the observed (Supplementary Fig. S5d). An alternative model involves direct Flk1-downregulation, for instance, by proteolytic cleavage that may scramble tip-stalk specification (Supplementary Fig. S8d-2). Another potential model is binding between VEGF and FN³⁷ that somehow contributes to tip-stalk association or specification (Supplementary Fig. S8d-3), which fits with our finding that FN may suppress the mislocalization of tip cells found in Reck cKO samples to some extent (Supplementary Fig. S8c; Fig. 5i).

Likewise, multiple models can be proposed to explain the increased cell proliferation found in Reck cKO cultures. Since Notch-signaling is known to confer quiescence to the vessels⁶, reduced Notch-ligands may promote cell proliferation. Alternatively, as observed in colon cancer cells³⁸, Reck-deficiency may promote cell cycle progression by upregulating Skp2, thereby downregulating the Cdk inhibitor p27. These issues need to be addressed in future studies.

We have previously speculated that dilated vessels found in Reck-deficient mice may result from impaired non-sprouting angiogenesis (i.e., intussusception)²⁷. The present data, however, support an alternative model that dilated vessels could result from aggregation and lateral fusion of excessive, unstable microvessels (Fig. 5j-4). Our data also raise the interesting possibility that Reck may serve as a key regulator of vascular morphogenesis by regulating the number and size of the vessels, the area covered by the vessels, as well as the site and timing of anastomoses (Fig. 5j). We also speculate that RECK-dysfunction may underlie various conditions that give rise to fragile, leaky blood vessels, such as cancers³⁹ and RASopathies⁴⁰, since several activated oncogenes, including mutated RAS, strongly suppress RECK expression^12,41. Compounds capable of upregulating endogenous RECK⁴² may be useful in ameliorating such conditions.

Methods

Mice

Animal experiments were approved by Animal Experimentation Committee, Kyoto University and conducted in accordance with its regulation. Generation and genotyping of mice carrying the Reck^CrER (also known as Reck-CreER^T2 or KI), Reck^E1fx (also known as R1), Reck^∆, or Reck^Low (also known as R2neo) allele has been described elsewhere²¹. To evaluate the roles of Reck in mural cells, Reck^+/∆ mice were crossed with mice carrying Sm22-Cre transgene³⁰ to obtain Reck^+/∆; Sm22-Cre male mice, which were then crossed with Reck^E1fx/E1fx female mice and their pups harvested at various stages for genotyping and morphological studies. To evaluate the roles of Reck in endothelial cells, Reck^+/∆ mice were crossed with Tie2-Cre transgenic mice³¹ to obtain Reck^+/∆; Tie2-Cre male mice, which were crossed with Reck^E1fx/E1fx female mice and their pups examined at various stages. To visualise cells expressing Tie2, Sm22, or Reck, female mice homozygous for the allele containing the mTmG transgene³² were crossed with male mice carrying the Tie2-Cre, Sm22-Cre, or Reck^CrER transgene to obtain pups carrying both the mTmG and Cre transgenes. To test the roles of Reck in microvessel formation in vitro, Reck^+/CrER; mTmG/mTmG male mice were crossed with Reck^E1fx/E1fx female mice (both in ICR background) and Reck^E1fx/CrER; mTmG mice (Reck cKO) were selected. To generate a matched control, Reck^+/CrER male mice were crossed with mTmG/mTmG female mice and Reck^+/CrER; mTmG mice (Cont) were selected. Mice carrying the Reck^CrER transgene were treated four times by daily intra-peritoneal injections of tamoxifen (80 mg/kg) and then two days later, aortae were harvested for ARA.

Histology

Mouse embryos were fixed, sliced (10 μm-thick) and stained with Hematoxylin and Eosin²¹, by immunohistochemistry with anti-CD31, anti-αSMA, or anti-laminin²⁷, or by Kluver-Barrera method⁴³ as described previously. Tissues from mice carrying the mTmG reporter were fixed, incubated overnight in 30% sucrose, embedded in O.C.T, frozen at –80 oC, sliced (5μm-thick) and observed with a fluorescent microscope.

Aortic ring assay

ARA was performed following the protocol of Baker et al.²⁹ with some modifications. The following conditions, optimised as shown in Supplementary Fig. S2, were used unless otherwise stated. Thoracic aortae were dissected from 5-week old transgenic mice after overnight starvation. The peri-aortic fibroadipose tissue and blood were carefully removed with fine microdissecting forceps and aorta tunics were preserved without damage. After cleaning, aortae were cut into 1 mm-thick rings, rinsed 3 times with PBS (−) and incubated overnight in Opti-MEM at 37 °C. The rings were then embedded in a mound of gel prepared on ice by mixing 5 volumes of 3 mg/ml collagen type I-A (Nitta Gelatin, Osaka, Japan), 3 volumes of 3 mg/ml collagen type IV (Nitta Gelatin, Osaka, Japan), 1 volume of 10× DMEM and 1 volume of reconstitution buffer (2.2 g NaHCO₃ in 100 ml of 0.05 N NaOH and 200 mM HEPES). For embedding, 50 μl of the collagen mixture was placed into wells of 96-well plates and incubated at 37 °C for 10 minutes to form a basal gel. Aortic rings were placed on the basal gel and covered with 10 μl of cold collagen mixture. After 20-min incubation at 37 °C, each well was fed with 200 μl Opti-MEM (Invitrogen) supplemented with 20 ng/ml VEGFa (R&D systems), 5% fetal horse serum (Cell Culture Laboratories, Ohio, USA), 100 U/ml penicillin and 100 μg/ml streptomycin. The dishes were tightly sealed with parafilm, kept at 37 °C for two weeks and examined every day under an inverted microscope. Micrographs were taken every day up to day 14 for morphometric analyses. In some experiments (Fig. 5c–i; Supplementary Fig. S7, S8c), bovine plasma fibronectin (Sigma, F1141) was added to the gel at 1 μg/ml.

Morphometry

Microscopic images were recorded with a digital camera at various time points and magnification, depending on the properties to be assessed: x40 on day 3 to 7 for microvessel growth (number and length), x100 on day 8 and 9 for microvessel width and x200 on day 10 to 14 for the cells associated with microvessels. The images were analysed using ImageJ to determine the length, width and anastomosis of microvessels and the area covered by them. The numbers of microvessels were counted manually, following the criteria described by Aplin et al.³³, where outgrowth constituted by singular cells such as fibroblasts, pericytes and macrophages or segmented sprout structures were not included. AngioTool⁴⁴ was also employed to quantify microvessel area, branching points (total junctions), total length, end points and lacunarity.

Immunofluorescent staining

Aortic rings extending microvessels were fixed with 4% formalin, permeabilised with 0.25% Triton-X for 15 min and incubated in PBS (+) containing 10% goat serum for 1 h at room temperature to block non-specific binding.After being rinsed with PBS (+) for 5 min they were then incubated overnight with primary antibody diluted in PBLEC²⁹. After rinsing with PBS (+) (3 × 10 min), samples were then incubated for 30 min at 37 °C in a cocktail of Alexa Fluor (488, 555, or Cy5) conjugated with appropriate secondary antibodies in PBLEC. Samples were rinsed then incubated (1 min) with Hoechst33342 and mounted using Fluoromount (Diagnostic BioSystems). Images were recorded using a fluorescence microscope (OlympusX70 or Keyence BZ-9000). The following primary antibodies were used: laminin (Progen 10765), CD31 (BD Pharmingen 550274), Reck [RECK-F, polyclonal rabbit antibodies (Matsuzaki et al., in preparation) and 5B11D12¹²]; α-Sma (DAKO MO85), fibronectin (BD Biosciences, 610078), PDGFR-beta (Santa Cruz Biotechnology sc-432), Flk-1 (Santa Cruz Biotechnology sc-625), LAMA5 (Sigma-Aldrich SAB4501720) and Ki67 (Leica Biosystems NCL-Ki67p).

Statistics

Quantitative data are presented in the form of mean ± sem in graphs. Significance of difference between two sets of data were assessed by Student’s t-test using the TTEST function in Excel (Microsoft) and the results are presented by symbols: *P < 0.05, **P < 0.01.

Additional Information

How to cite this article: Almeida, G. M. et al. Critical roles for murine Reck in the regulation of vascular patterning and stabilization. Sci. Rep. 5, 17860; doi: 10.1038/srep17860 (2015).

Change history

04 March 2016
A correction has been published and is appended to both the HTML and PDF versions of this paper. The error has not been fixed in the paper.

References

Yancopoulos, G. D. et al. Vascular-specific growth factors and blood vessel formation. Nature 407, 242–248 (2000).
Article CAS PubMed Google Scholar
Dvorak, H. F. Discovery of vascular permeability factor (VPF). Exp Cell Res 312, 522–526 (2006).
Article CAS PubMed Google Scholar
Saharinen, P., Bry, M. & Alitalo, K. How do angiopoietins Tie in with vascular endothelial growth factors? Curr Opin Hematol 17, 198–205 (2010).
CAS PubMed Google Scholar
Carmeliet, P. & Jain, R. K. Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298–307 (2011).
Article ADS CAS PubMed Google Scholar
Chung, A. S. & Ferrara, N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol 27, 563–584 (2011).
Article CAS PubMed Google Scholar
Geudens, I. & Gerhardt, H. Coordinating cell behaviour during blood vessel formation. Development 138, 4569–4583 (2011).
Article CAS PubMed Google Scholar
Andrae, J., Gallini, R. & Betsholtz, C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22, 1276–1312 (2008).
Article CAS PubMed Google Scholar
Senger, D. R. & Davis, G. E. Angiogenesis. Cold Spring Harb Perspect Biol 3, a005090 (2011).
Article PubMed Google Scholar
Stratman, A. N. & Davis, G. E. Endothelial cell-pericyte interactions stimulate basement membrane matrix assembly: influence on vascular tube remodeling, maturation and stabilization. Microsc Microanal 18, 68–80 (2011).
Article ADS PubMed Google Scholar
Page-McCaw, A., Ewald, A. J. & Werb, Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8, 221–233 (2007).
Article CAS PubMed Google Scholar
Kessenbrock, K., Plaks, V. & Werb, Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52–67 (2010).
Article CAS PubMed Google Scholar
Takahashi, C. et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 95, 13221–13226 (1998).
Article ADS CAS PubMed Google Scholar
Oh, J. et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107, 789–800 (2001).
Article CAS PubMed Google Scholar
Noda, M. et al. RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastasis Rev 22, 167–175 (2003).
Article CAS PubMed Google Scholar
Miki, T. et al. The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) interacts with membrane type 1 matrix metalloproteinase and CD13/aminopeptidase N and modulates their endocytic pathways. J Biol Chem 282, 12341–12352 (2007).
Article CAS PubMed Google Scholar
Muraguchi, T. et al. RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity. Nat Neurosci 10, 838–845 (2007).
Article CAS PubMed Google Scholar
Noda, M. & Takahashi, C. Recklessness as a hallmark of aggressive cancer. Cancer Sci 98, 1659–1665 (2007).
Article CAS PubMed Google Scholar
Omura, A. et al. RECK forms cowbell-shaped dimers and inhibits matrix metalloproteinase-catalyzed cleavage of fibronectin. J Biol Chem 284, 3461–3469 (2009).
Article CAS PubMed Google Scholar
Hatta, M. et al. Density- and serum-dependent regulation of the Reck tumor suppressor in mouse embryo fibroblasts. Cell Signal 21, 1885–1893 (2009).
Article CAS PubMed Google Scholar
Loayza-Puch, F. et al. Hypoxia and RAS-signaling pathways converge on and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs. Oncogene 29, 2638–2648 (2010).
Article CAS PubMed Google Scholar
Yamamoto, M. et al. The transformation suppressor gene Reck is required for postaxial patterning in mouse forelimbs. Biol Open 1, 458–466 (2012).
Article CAS PubMed Google Scholar
Gabriely, G. et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 28, 5369–5380 (2008).
Article CAS PubMed Google Scholar
Wang, H. et al. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis 32, 1033–1042 (2011).
Article CAS PubMed Google Scholar
Jung, H. M. et al. Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer. J Biol Chem 287, 29261–29272 (2012).
Article CAS PubMed Google Scholar
Li, N. et al. Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett 586, 722–728 (2012).
Article ADS CAS PubMed Google Scholar
Hirata, H. et al. MicroRNA-182-5p promotes cell invasion and proliferation by down regulating FOXF2, RECK and MTSS1 genes in human prostate cancer. PLoS One 8, e55502 (2013).
Article ADS CAS PubMed Google Scholar
Chandana, E. P. et al. Involvement of the Reck tumor suppressor protein in maternal and embryonic vascular remodeling in mice. BMC Dev Biol 10, 84 (2010).
Article PubMed Google Scholar
Nicosia, R. F. & Ottinetti, A. Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab Invest 63, 115–122 (1990).
CAS PubMed Google Scholar
Baker, M. et al. Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc 7, 89–104 (2011).
Article PubMed Google Scholar
Holtwick, R. et al. Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci USA 99, 7142–7147 (2002).
Article ADS CAS PubMed Google Scholar
Kisanuki, Y. Y. et al. Tie2-Cre transgenic mice: a new model for endothelial cell-lineage analysis in vivo. Dev Biol 230, 230–242 (2001).
Article CAS PubMed Google Scholar
Muzumdar, M. D. et al. A global double-fluorescent Cre reporter mouse. Genesis 45, 593–605 (2007).
Article CAS PubMed Google Scholar
Aplin, A. C., Fogel, E., Zorzi, P. & Nicosia, R. F. The aortic ring model of angiogenesis. Methods Enzymol 443, 119–136 (2008).
Article CAS PubMed Google Scholar
Morioka, Y. et al. The membrane-anchored metalloproteinase regulator RECK stabilizes focal adhesions and anterior-posterior polarity in fibroblasts. Oncogene 28, 1454–1464 (2009).
Article CAS PubMed Google Scholar
Yuki, K. et al. E-cadherin-downregulation and RECK-upregulation are coupled in the non-malignant epithelial cell line MCF10A but not in multiple carcinoma-derived cell lines. Sci Rep 4, 4568 (2014).
Article PubMed Google Scholar
Betsholtz, C. Insight into the physiological functions of PDGF through genetic studies in mice. Cytokine Growth Factor Rev 15, 215–228 (2004).
Article CAS PubMed Google Scholar
Wijelath, E. S. et al. Novel vascular endothelial growth factor binding domains of fibronectin enhance vascular endothelial growth factor biological activity. Circ Res 91, 25–31 (2002).
Article CAS PubMed Google Scholar
Yoshida, Y., Ninomiya, K., Hamada, H. & Noda, M. Involvement of the SKP2-p27(KIP1) pathway in suppression of cancer cell proliferation by RECK. Oncogene 31, 4128–4138 (2012).
Article CAS PubMed Google Scholar
Goel, S. et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91, 1071–1121 (2011).
Article CAS PubMed Google Scholar
Rauen, K. A. The RASopathies. Annu Rev Genomics Hum Genet 14, 355–369 (2013).
Article CAS PubMed Google Scholar
Sasahara, R. M., Takahashi, C. & Noda, M. Involvement of the Sp1 site in ras-mediated downregulation of the RECK metastasis suppressor gene. Biochem Biophys Res Commun 264, 668–675 (1999).
Article CAS PubMed Google Scholar
Murai, R. et al. A novel screen using the Reck tumor suppressor gene promoter detects both conventional and metastasis-suppressing anticancer drugs. Oncotarget 1, 252–264 (2010).
Article PubMed Google Scholar
Kluver, H. & Barrera, E. A method for the combined staining of cells and fibers in the nervous system. J Neuropathol Exp Neurol 12, 400–403 (1953).
Article CAS PubMed Google Scholar
Zudaire, E., Gambardella, L., Kurcz, C. & Vermeren, S. A computational tool for quantitative analysis of vascular networks. PLoS One 6, e27385 (2011).
Article ADS CAS PubMed Google Scholar

Download references

Acknowledgements

This work was supported by KAKENHI [Grants-in-Aid for Creative Scientific Research, Scientific Research on Priority Areas and Scientific Research on Innovative Areas]. G.M.A. was a MEXT fellow. We are grateful to Emi Nishimoto, Hai-Ou Gu, Mika Fujiwara and Kumi Kawade for technical assistance, Aki Miyazaki for secretarial assistance and Claire Whitworth for critical reading of the manuscript.

Author information

Mako Yamamoto
Present address: Gene Expression Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, California, 92037, USA
de Almeida Glícia Maria and Yamamoto Mako contributed equally to this work.

Authors and Affiliations

Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan
Glícia Maria de Almeida, Mako Yamamoto, Yoko Morioka, Shuichiro Ogawa, Tomoko Matsuzaki & Makoto Noda

Authors

Glícia Maria de Almeida
View author publications
You can also search for this author in PubMed Google Scholar
Mako Yamamoto
View author publications
You can also search for this author in PubMed Google Scholar
Yoko Morioka
View author publications
You can also search for this author in PubMed Google Scholar
Shuichiro Ogawa
View author publications
You can also search for this author in PubMed Google Scholar
Tomoko Matsuzaki
View author publications
You can also search for this author in PubMed Google Scholar
Makoto Noda
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

M.Y., T.M. and M.N. designed and M.Y. and G.M.A. performed, the experiments in vivo. T.M., G.M.A. and M.N. designed and G.M.A. performed, most of the experiments in vitro. Y.M. and S.O. helped some experiments in vitro. T.M. and M.N. organized and supervised the study. G.M.A. and M.N. prepared the manuscript with the help of other authors.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Electronic supplementary material

Supplementary Information

Rights and permissions

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Reprints and permissions

About this article

Cite this article

de Almeida, G., Yamamoto, M., Morioka, Y. et al. Critical roles for murine Reck in the regulation of vascular patterning and stabilization. Sci Rep 5, 17860 (2015). https://doi.org/10.1038/srep17860

Download citation

Received: 28 May 2015
Accepted: 28 October 2015
Published: 11 December 2015
DOI: https://doi.org/10.1038/srep17860

This article is cited by

Suppression of tumor metastasis by a RECK-activating small molecule
- Yoko Yoshida
- Kanako Yuki
- Makoto Noda
Scientific Reports (2022)

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.